Home › About NIDA › Organization › Workgroups, Interest Groups and Consortia › Neuroscience Consortium › Frontiers in Addiction › Frontiers 2011
External link, please review our disclaimer.
Frontiers in Addiction Research 2011
About NIDA
- 2010 Strategic Plan
- Organization
- Offices
- CCTN
- Divisions
- Workgroups, Interest Groups and Consortia
- AIDS Workgroup
- Child & Adolescent Workgroup (CAWG)
- Community Epidemiology Work Group (CEWG)
- Genetics Workgroup (GWG)
- Prescription Opioid and Pain Workgroup (POP)
- Translationally-Oriented Approaches, Devices & Strategies (TOADS) Workgroup
- Women & Sex/Gender Differences Research Group (WGRG)
- Nicotine/Tobacco Interest Group
- Neuroscience Consortium
- Director's Page
- Legislative Activities
- Advisory Boards & Groups
- Employment Opportunities
- Donating to NIDA
- Contact Us
- Other Resources
NIDA’s Neuroscience Consortium organized the 10th annual Frontiers in Addiction Research Mini-Convention held at the 2011 Society for Neuroscience Meeting on November 11, 2011, in Washington, DC. The mini-convention included sessions on autism, addiction, and the role of the MeCP2 gene in mediating response to drugs; synapse organization, and plasticity and its relationship to drug addiction; using optogenetics to shed light on the neural mechanisms of addiction; and the neurobiology of behavioral and emotional regulation/dysregulation.
Session Summaries
- Autism, Addiction and MeCP2
- Using Optogenetics to Shed Light on the Neural Mechanisms of Addiction
- Neurobiology of Behavioral and Emotional Regulation/Dysregulation
Videos
This page was last updated September 18, 2012.
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.